Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Magnesium Supplementation With Botulinum Toxin Type A for Excessive Gingival Display
NCT07874009Enrolling by invitation
- Sponsor
- Cairo University
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Randomised trial of magnesium bisglycinate in excessive gingival display (2 arms), sponsored by Cairo University. Primary endpoint: Change in gingival display at 6 weeks. Started Oct 2026; status: enrolling by invitation.
02
Drugs
magnesium bisglycinate
03
Conditions
excessive gingival display
Beyond the preview
Go deeper on NCT07874009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07874009.